Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant PCSK9 (Alirocumab Biosimilar) antibody

Research Grade Reactivity: Human ELISA Host: Mammalian Cells Monoclonal unconjugated Recombinant Antibody
Catalog No. ABIN7487990
  • Target
    PCSK9 (Alirocumab Biosimilar)
    Antibody Type
    Recombinant Antibody
    Reactivity
    Human
    Host
    Mammalian Cells
    Expression System
    Mammalian cells
    Clonality
    Monoclonal
    Application
    ELISA
    Purpose
    Alirocumab Biosimilar - Anti-PCSK9 mAb
    Characteristics
    Antibody Type: IgG1-kappa
    Purification
    Recombinant antibody expressed in mammalien cells and purified.
    Grade
    Research Grade
    Isotype
    IgG1 kappa
  • Restrictions
    For Research Use only
  • Buffer
    PBS pH 7.5
    Storage
    -80 °C
    Storage Comment
    store at -80°C
  • Target
    PCSK9 (Alirocumab Biosimilar)
    Target Type
    Biosimilar
    Background
    REGN727,SAR-236553
    Alirocumab is a human IgG2 monoclonal antibody that binds to and prevents the binding of the proprotein convertase subtilisin/kexin type 9 (PCSK9). PCSK9 is a protein that binds to LDL receptors for degradation, thus reducing the liver’s activity of removal of LDL-cholesterol (LDL-C) from the blood. It is used in the treatment of hyperlipidemia.
    CAS-No
    1245916-14-6
You are here:
Support